The proposed approach is applied to simulate the insulin-glucose regulatory system under different pathological conditions, including type 1 diabetes, type 2 diabetes, hyperinsulinemia, and hypoglycemia. This evidence concerns the gene INS and type 1 diabetes mellitus.